Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer
ConclusionsThis study achieved a high pCR rate with favorable toxicity and postoperative complications in poor-risk locally advanced low rectal cancer. Multicenter study is warranted to evaluate this regimen.
Source: Annals of Surgical Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Avastin | Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Laparoscopy | MRI Scan | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Oral Cancer | Rectal Cancers | Study | Toxicology